Biogenesis
PrivateLast Round
Seed
Mar 1, 2024
Total Funding Raised
$2.75M
Company Overview
Biogenesis operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Seed round in March 2024.
Biogenesis is a healthcare technology company that provides an AI-powered platform designed to accelerate clinical trials by matching pharmaceutical organizations with suitable clinical research sites.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biogenesis Comparables
Compare Biogenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inato | 79% | |
| Paradigm Health | 75% | |
| TriNetX | 74% |
For institutional investors. Book with your work email.
Biogenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 1, 2024 | ||||
| Pre Seed | Oct 2, 2022 |
For institutional investors. Book with your work email.
Biogenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UC LAUNCH | Pre Seed |
| Alt Capital | Seed |
| Kleiner Perkins | Pre Seed |
| Nucleate | Pre Seed |
| Pareto Holdings | Pre Seed |
| Z Fellows | Pre Seed |
| Formic Ventures | Pre Seed |
Biogenesis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biogenesis's valuation, stock price, and market status.
Is Biogenesis a public or private company?
Biogenesis is a private company.
What is the current stock price of Biogenesis?
Biogenesis is a private company, so its shares have no public market price. Caplight tracks Biogenesis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biogenesis worth (valuation)?
Valuation information for Biogenesis is not publicly available.
Can I buy Biogenesis stock?
Biogenesis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biogenesis's last funding round?
Biogenesis's most recent funding round was Seed on March 1, 2024.
Who are the main investors in Biogenesis?
Key investors in Biogenesis include UC LAUNCH, Alt Capital, Kleiner Perkins, Nucleate, Pareto Holdings.
Will Biogenesis IPO soon?
No public IPO plans have been announced for Biogenesis.
How can I track Biogenesis secondary market activity?
Caplight tracks bids, offers, and trades in Biogenesis's shares on secondary markets.